AIM: The “2026 Guideline for the Early Management of Patients With AIS” replaces the “2018 Guidelines for the Early Management of Patients With AIS” and the 2019 update to reflect recent advances in ...

Google has rolled out fewer confirmed search ranking updates in 2025, then it did in all the past years where Google confirmed these updates. Google rolled out only four confirmed updates in 2025, ...

Google launched four official and confirmed algorithmic updates in 2025, three core updates and one spam update. This is in comparison to last year, in 2024, where we had seven confirmed updates, then ...

LONDON, Dec 10 (Reuters) - Roche (ROG.S), opens new tab said on Wednesday its experimental oral drug giredestrant reduced the risk of breast cancer recurrence by 30% compared with standard endocrine ...

FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann/File Photo LONDON, Dec 10 (Reuters) - Roche said on Wednesday ...

You chose selected. Each dot here represents a single video about selected. While you’re on the app, TikTok tracks how you interact with videos. It monitors your watch time, the videos you like, the ...

Retention analysts say Shorts older than 28-30 days are being deprioritized in recommendations. The reported shift affects channels ranging from 100 million to one billion monthly views. Creators warn ...

A new study of adolescents and young adults (AYAs) with seven common cancers reveals that nearly one in ten patients diagnosed with non-metastatic disease later develop metastatic recurrence - a ...

In 2025, the Instagram algorithm has become more advanced than ever, using artificial intelligence and machine learning to decide what content users see in their Feeds, Reels, Stories, Explore pages, ...

When Edsger W. Dijkstra published his algorithm in 1959, computer networks were barely a thing. The algorithm in question found the shortest path between any two nodes on a graph, with a variant ...

Adjuvant trastuzumab deruxtecan (T-DXd; Enhertu) significantly improved invasive disease-free survival compared with trastuzumab emtansine (T-DM1; Kadcyla) in high-risk HER2-positive early breast ...

Ben Khalesi writes about where artificial intelligence, consumer tech, and everyday technology intersect for Android Police. With a background in AI and Data Science, he’s great at turning geek speak ...